Covestor’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20K Sell
2,416
-267
-10% -$1.78K 0.01% 1182
2026
Q1
$15K Buy
2,683
+1,017
+61% +$5.71K 0.01% 1241
2025
Q4
$12K Sell
1,666
-162
-9% -$1.27K 0.01% 1500
2025
Q3
$15K Sell
1,828
-475
-21% -$3.71K 0.01% 1412
2025
Q2
$20K Buy
2,303
+380
+20% +$2.75K 0.01% 1257
2025
Q1
$16K Sell
1,923
-245
-11% -$2.48K 0.01% 1270
2024
Q4
$20K Sell
2,168
-2,310
-52% -$22.3K 0.01% 1199
2024
Q3
$41K Buy
4,478
+603
+16% +$4.99K 0.03% 945
2024
Q2
$38K Buy
3,875
+58
+2% +$707 0.02% 971
2024
Q1
$57K Buy
3,817
+1,403
+58% +$25.5K 0.04% 835
2023
Q4
$52K Buy
2,414
+2,080
+623% +$38.4K 0.04% 835
2023
Q3
$6K Sell
334
-5
-1% -$117 ﹤0.01% 1697
2023
Q2
$9K Sell
339
-1
-0.3% -$25 0.01% 1533
2023
Q1
$9K Sell
340
-88
-21% -$2.35K 0.01% 1388
2022
Q4
$10K Buy
428
+175
+69% +$4.72K 0.01% 1344
2022
Q3
$6K Sell
253
-345
-58% -$12.1K 0.01% 1456
2022
Q2
$19K Sell
598
-489
-45% -$20.8K 0.02% 995
2022
Q1
$78K Buy
1,087
+1,027
+1,712% +$74K 0.05% 652
2021
Q4
$6K Buy
+60
New +$7.17K 0.01% 1261

Other funds holding TDOC

Covestor's TDOC Position: Q2 2026 in Review

Covestor reduced its Teladoc Health (TDOC) stake by 10% in Q2 2026, selling an estimated $1.78K and leaving 2,416 shares worth $20K. The position accounts for 0.01% of the portfolio, ranked #1182.

Covestor first reported a position in TDOC in Q4 2021 and has held it in 19 quarters since. The position peaked at $78K in Q1 2022. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Covestor held 2,416 shares of Teladoc Health worth $20K as of Q2 2026.
  • Covestor sold 267 Teladoc Health shares in Q2 2026, an estimated $1.78K.
  • Teladoc Health made up 0.01% of Covestor's portfolio in Q2 2026, its #1182 holding.
  • Covestor first reported a position in Teladoc Health in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Teladoc Health position peaked at $78K in Q1 2022.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.